| A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan (NCT01197014) | Hanmi Pharmaceutical Company Limited | 2010-09-01 |
| Study to Assess the Distribution, Metabolism and Excretion of [14C]AZD6765 After a Single-Dose Intravenous Administration (NCT01217645) | AstraZeneca | 2010-09-01 |
| A Study To Evaluate The Effect Of Food On How Tasocitinib (CP-690,550) Is Absorbed And Moves Through The Body Following Oral Administration Of Tasocitinib (CP-690,550) Tablets To Healthy Subjects (NCT01184001) | Pfizer | 2010-09-01 |
| Estimate The Effect Of Repeat-Dose Rifampin On The Pharmacokinetics Of CP-690,550 In Healthy Volunteers (NCT01204112) | Pfizer | 2010-09-01 |
| Dose-escalation, Safety, Pharmacokinetics Study of AVE8062 Combined With Bevacizumab in Patients With Advanced Solid Tumors (NCT01193595) | Sanofi | 2010-09-01 |
| Effect of GSK962040 on Oesophageal Function (NCT01366560) | GlaxoSmithKline | 2010-08-31 |
| An Extension Protocol for Subjects Who Were Previously Enrolled in Other Tivantinib (ARQ 197) Protocols (NCT01178411) | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 2010-08-31 |
| SPD544 High Strength Bioequivalence Study (NCT01183234) | Shire | 2010-08-27 |
| A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's Disease (NCT01211977) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2010-08-27 |
| Lenalidomide and High Dose Melphalan Followed by Autologous Stem Cell Transplant in Multiple Myeloma (NCT01142232) | Attaya Suvannasankha | 2010-08-27 |
| Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma (NCT01057121) | National Cancer Institute (NCI) | 2010-08-27 |
| A Study to Investigate the Effect of GDC-0449 on the QT/QTc Interval in Healthy Female Subjects (NCT01173536) | Genentech, Inc. | 2010-08-25 |
| EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) (NCT01186328) | Therapeutic Advances in Childhood Leukemia Consortium | 2010-08-24 |
| Trial of PD 0332991 Plus Bortezomib in Patients With Relapsed Mantle Cell Lymphoma (NCT01111188) | Weill Medical College of Cornell University | 2010-08-23 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Insulin (IN-105) in Type 1 Diabetes Patients (NCT01035801) | Biocon Limited | 2010-08-21 |
| Safety Study of a Gene Transfer Vector (Rh.10) for Children With Late Infantile Neuronal Ceroid Lipofuscinosis (LINCL) (NCT01161576) | Weill Medical College of Cornell University | 2010-08-19 |
| Safety, Pharmacodynamics, and Pharmacokinetics of Different Dosing Regimens of MK-8266 in Participants With Hypertension (MK-8266-008) (NCT01244035) | Merck Sharp & Dohme LLC | 2010-08-19 |
| Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer (NCT01187199) | M.D. Anderson Cancer Center | 2010-08-19 |
| A Phase 1 Study of Alisertib Participants With Advanced Solid Tumors Including Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel Regimen (NCT01094288) | Millennium Pharmaceuticals, Inc. | 2010-08-17 |
| Phase I Methodology Study to Validate the Cantharidin Blister Model in Healthy Volunteers (NCT01762787) | GlaxoSmithKline | 2010-08-17 |
| A Study to Evaluate Pazopanib Tablets in Patients Who Have Neovascular Age-related Macular Degeneration (NCT01154062) | GlaxoSmithKline | 2010-08-16 |
| Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV Melanoma (NCT01176474) | H. Lee Moffitt Cancer Center and Research Institute | 2010-08-13 |
| Effect of GLP-1 on Insulin Biosynthesis and Turnover Rates (NCT00609154) | Albert Einstein College of Medicine | 2010-08-12 |
| Sorafenib and Vorinostat in Treating Patients With Advanced Liver Cancer (NCT01075113) | Virginia Commonwealth University | 2010-08-10 |
| Vorinostat and Radiation Therapy Followed by Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (NCT01189266) | National Cancer Institute (NCI) | 2010-08-09 |
| Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy (NCT01003691) | Pfizer | 2010-08-05 |
| A Study of E7080 Alone, and in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Renal Cell Carcinoma Following One Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Treatment (NCT01136733) | Eisai Inc. | 2010-08-05 |
| Helium-3 MRI Imaging Study in COPD (NCT02207452) | GlaxoSmithKline | 2010-08-05 |
| Multiple Class I Peptides & Montanide ISA 51 VG w Escalating Doses of Anti-PD-1 ab BMS936558 (NCT01176461) | H. Lee Moffitt Cancer Center and Research Institute | 2010-08-04 |
| Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell Transplantation (NCT01087294) | National Cancer Institute (NCI) | 2010-08-04 |
| A Study of EUR-1066 in Subjects With Chronic Pancreatitis, Exocrine Pancreatic Insufficiency and Chronic Abdominal Pain (NCT01159119) | Forest Laboratories | 2010-08-02 |
| Lenalidomide Plus Melphalan as a Preparative Regimen for Autologous Stem Cell Transplantation in Relapsed Multiple Myeloma: A Phase 1 / 2 Study (NCT01054196) | Weill Medical College of Cornell University | 2010-08-01 |
| Single-dose Iloperidone Pharmacokinetics in Patients With Mild or Moderate Liver Disease, Compared to Healthy Volunteers (NCT01529294) | Novartis Pharmaceuticals | 2010-08-01 |
| Study of Bendamustine Hydrochloride for the Treatment of Pediatric Patients With Relapsed or Refractory Acute Leukemia (NCT01088984) | Teva Branded Pharmaceutical Products R&D, Inc. | 2010-08-01 |
| STA-9090 in Patients With Advanced Hepatocellular Cancer (NCT01665937) | Massachusetts General Hospital | 2010-08-01 |
| A Nursing Intervention to Enhance Child Comfort and Psychological Well-Being During and Following PICU Hospitalization (NCT01176188) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2010-08-01 |
| A Multiple Ascending Dose Study of GS 5885 in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C (NCT01193478) | Gilead Sciences | 2010-08-01 |
| Study of NK012 and 5-FU/LV in Solid Tumors Followed by Dose Expansion in Colorectal Cancer (NCT01238939) | Nippon Kayaku Co., Ltd. | 2010-08-01 |
| Study to Assess Safety,Tolerability,Pharmacokinetics & Antiviral Activity of JTK-853 in Hepatitis C Virus Genotype 1 Infected Subjects (NCT01473056) | Akros Pharma Inc. | 2010-08-01 |
| Subcutaneous Administration of Teplizumab in Adults With Type 1 Diabetes (NCT01189422) | MacroGenics | 2010-08-01 |
| Acute Response Capsaicin Flare Study (NCT01147432) | Pfizer | 2010-08-01 |
| A Study of Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic Cancer (NCT01189929) | OncoMed Pharmaceuticals, Inc. | 2010-08-01 |
| Plerixafor and Clofarabine in Frontline Treatment of Elderly Patients With Acute Myelogenous Leukemia (AML) (NCT01160354) | M.D. Anderson Cancer Center | 2010-08-01 |
| Metabolic Reprogramming Therapy for Treatment of Recurrent Head and Neck Cancers (NCT01163487) | Daniel T. Chang | 2010-08-01 |
| Botox Injection for Treatment of Vaginismus (NCT01352546) | Plastic Surgery Professional Association | 2010-08-01 |
| Lung Deposition of the BDP/Formoterol Combination Administered Via the NEXT DPI in Healthy, Asthmatic and COPD Patients (NCT01176747) | Chiesi Farmaceutici S.p.A. | 2010-08-01 |
| An Interactive Informed Consent and Education Program for Pregnant Women (NCT01176019) | Northwestern University | 2010-08-01 |
| Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 Given in a 3 Days on / 4 Days Off Schedule in Subjects With Advanced Malignancies (NCT01188252) | Bayer | 2010-08-01 |
| The Effect of Combined Ephedrine and Lidocaine Pretreatment on Pain and Hemodynamic Changes Due to Propofol Injection (NCT01186549) | Qazvin University Of Medical Sciences | 2010-08-01 |
| The Effect of Oral Hygiene and Full Mouth Scaling on Metabolic Control in Patients With Type II Diabetes (NCT01255254) | Rambam Health Care Campus | 2010-08-01 |
| Behavioral and Physiological Effects of Cocaine in Cocaine-dependent Participants Treated With Levodopa in Combination With Carbidopa and Entacapone (LCE) (NCT01437293) | New York State Psychiatric Institute | 2010-08-01 |
| Peptide Vaccination Associated With Tumoral Immunomodulation in Patients With Advanced Metastatic Melanoma (NCT01191034) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2010-08-01 |
| Bioequivalence Study of Lamotrigine Extended-Release Tablets 200mg Under Fed Condition (NCT01888263) | Dr. Reddy's Laboratories Limited | 2010-08-01 |
| SBRT for Organ Confined Prostate Cancer (NCT02653248) | Northwell Health | 2010-08-01 |
| Single Dose Study Of PF-04308515 And Prednisone On Carbohydrate (NCT01199029) | Pfizer | 2010-08-01 |
| Drug-Drug Interaction Study With Rifampin (NCT01002079) | Bristol-Myers Squibb | 2010-08-01 |
| Positron Emission Tomography (PET) Imaging of Glial Activation in Psychotic Disease States (NCT03257592) | Johns Hopkins University | 2010-08-01 |
| A Study To Compare The Amount Of Tasocitinib (CP-690,550) That Is Absorbed Into The Blood Of Healthy Subjects Following Oral Administration Of Three Different Tablet Versions Of Tasocitinib (CP-690,550) (NCT01184092) | Pfizer | 2010-08-01 |
| A Study to Evaluate Cardiovascular Interactions Between Mirabegron and Tamsulosin (NCT01489696) | Astellas Pharma Inc | 2010-08-01 |
| Progesterone Microspheres Pharmacokinetic - Pharmacodynamic (PK-PD) Study (NCT01176175) | Productos Científicos S. A. de C. V. | 2010-08-01 |
| A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment Failures (NCT01185028) | National Institutes of Health Clinical Center (CC) | 2010-08-01 |
| Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients (NCT01169584) | Jennerex Biotherapeutics | 2010-08-01 |
| Safety Study of an Immunomodulating Microparticle to Treat Progressive Multiple Sclerosis (NCT01191996) | Innate Immunotherapeutics | 2010-08-01 |
| A Bioequivalence Study of SCH 530348 2.5 mg Tablets (P06558) (NCT01358344) | Merck Sharp & Dohme LLC | 2010-08-01 |
| A Phase 1 Absolute Bioavailability Study For Oral Crizotinib In Healthy Volunteers (NCT01168934) | Pfizer | 2010-08-01 |
| Effect of 7 Days of Dosing With a 10 mg Rectal Suppository of NRL001in Patients With Faecal Incontinence (NCT01175941) | Norgine | 2010-08-01 |
| A Bioavailability Study Comparing Treprostinil Diethanolamine Oral Tablets and Oral Solution in Healthy Volunteers (NCT01172496) | United Therapeutics | 2010-08-01 |
| Phase 1 Nilotinib in Steroid Dependent/Refractory Chronic Graft Versus Host Disease (NCT01155817) | Stanford University | 2010-08-01 |
| HIV/STI Prevention for Adolescents With Substance Use Disorders in Treatment (NCT01383837) | New York State Psychiatric Institute | 2010-08-01 |
| A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia (NCT01187017) | National Heart, Lung, and Blood Institute (NHLBI) | 2010-08-01 |
| Open Label Prostate Cancer Study (NCT01162395) | AstraZeneca | 2010-08-01 |
| Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignancies (NCT01182168) | Memorial Sloan Kettering Cancer Center | 2010-08-01 |
| A Study of RO5045337 in Patients With Solid Tumors (NCT01164033) | Hoffmann-La Roche | 2010-08-01 |
| Efficacy and Safety of Sub-tenon Ranibizumab for Recurrent Pterygia (NCT01169909) | University of New Mexico | 2010-08-01 |
| Triple Therapy of Pars Plana Vitrectomy and Grid/Focal Laser for Diabetic Macular Edema (DME) (NCT01202461) | Samsung Medical Center | 2010-08-01 |
| Super-Selective Intraarterial Cerebral Infusion Of Temozolomide (Temodar) For Treatment Of Newly Diagnosed GBM And AA (NCT01180816) | Northwell Health | 2010-08-01 |
| Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma (NCT01241162) | University of Louisville | 2010-08-01 |
| EP1300 Polyepitope DNA Vaccine Against Plasmodium Falciparum Malaria (NCT01169077) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-08-01 |
| Bioequivalence Study of Lamotrigine Extended-Release Tablets 50 mg Under Fasting Condition (NCT01888731) | Dr. Reddy's Laboratories Limited | 2010-08-01 |
| A Trial Investigating the Exposure of NN5401 in Young Adults and Elderly Subjects With Type 1 Diabetes (NCT01174303) | Novo Nordisk A/S | 2010-08-01 |
| Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Combination With Cisplatin, Vinblastine, and Temozolomide in Treating Patients With Recurrent or Metastatic Melanoma (NCT01196416) | National Cancer Institute (NCI) | 2010-08-01 |
| To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding In Brain Using PET (Positron Emission Tomography) In Healthy Volunteers (NCT01173757) | Pfizer | 2010-08-01 |
| Pharmacodynamic and Pharmacokinetic Variability of a Basal Insulin (0000-168) (NCT01152242) | Merck Sharp & Dohme LLC | 2010-08-01 |
| A Study Of Combined C- MET Inhibitor And PAN-HER Inhibitor (PF-02341066 And PF-00299804) In Patients With Non- Small Cell Lung Cancer (NCT01121575) | Pfizer | 2010-08-01 |
| Selenium Status Measured in Blood After a Higher Intake of Fish and Shellfish - a Randomized Dietary Intervention Study (NCT01224249) | Danish Cancer Society | 2010-08-01 |
| TAK-438_110 Drug Interaction With Cytochrome P450 3A4 (CYP3A4) Inhibitor Clarithromycin (NCT02774902) | Takeda | 2010-08-01 |
| Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid Tumors (NCT01198184) | National Cancer Institute (NCI) | 2010-08-01 |
| A Drug Interaction Study of 31001074 and Paroxetine in Healthy Volunteers (NCT01159821) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2010-08-01 |
| Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia (NCT01174888) | Alison Walker | 2010-08-01 |
| Telmisartan, Amlodipine and Combination in Healthy Subjects (NCT01181011) | Boehringer Ingelheim | 2010-08-01 |
| Enhancement of Functional Recovery After Peripheral Nerve Injury With Tacrolimus (NCT00950391) | Washington University School of Medicine | 2010-08-01 |
| Triazolam Trial In Healthy Subjects To Compare Bioavailability Between Formulations Of Triazolam To Determine Their Bioequivalence In Terms Of Rate And Magnitude Of Absorption (NCT01017926) | Pfizer | 2010-08-01 |
| Modafinil - Escitalopram Study for Cocaine Dependence (NCT01601730) | Baylor College of Medicine | 2010-08-01 |
| Pharmacodynamics of Lorelin Depot (Leuprorelin Acetate - Bergamo) Compared to Lupron Depot ® (Leuprorelin Acetate - Abbot) (NCT01071005) | Azidus Brasil | 2010-08-01 |
| EMD 1201081 + 5-FU + Cisplatin + Cetuximab in Subjects With Recurrent / Metastatic Squamous Cell Carcinoma of the Head and Neck (NCT01360827) | Merck KGaA, Darmstadt, Germany | 2010-08-01 |
| Study of ABT-267 in Both Healthy Volunteers and Hepatitis C Virus (HCV) Genotype 1 Infected Subjects (NCT01181427) | Abbott | 2010-08-01 |
| Pharmacokinetic Study to Characterize Individual Metabolic Profile (NCT01188525) | Institut National de la Santé Et de la Recherche Médicale, France | 2010-08-01 |
| TAP Block for Open Radical Prostatectomy. (NCT01157546) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2010-08-01 |
| A Multiple Dose Study Of PF-05161704 In Healthy Volunteers (NCT01202266) | Pfizer | 2010-08-01 |
| First-in-Human Single Ascending and Multiple Dose of GLPG0634 (NCT01179581) | Lakefront Biotherapeutics NV | 2010-08-01 |